di-tert-butyl 7,7'-(octanedioylbis(azanediyl))bis(5-(benzyloxy)-1-(chloromethyl)-1,2-dihydro-3H-benzo[e]indole-3-carboxylate) | 261763-51-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: di-tert-butyl 7,7'-(octanedioylbis(azanediyl))bis(5-(benzyloxy)-1-(chloromethyl)-1,2-dihydro-3H-benzo[e]indole-3-carboxylate)
• CAS: 261763-51-3
• 化学式: C₅₈H₆₄Cl₂N₄O₈
• 分子量: 1016.07
• InChiKey: DJJLWSNXQVVUSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  14.22
• 重原子数：
  72.0
• 可旋转键数：
  17.0
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  135.74
• 氢给体数：
  2.0
• 氢受体数：
  8.0

反应信息

• 作为反应物：
  描述：

  di-tert-butyl 7,7'-(octanedioylbis(azanediyl))bis(5-(benzyloxy)-1-(chloromethyl)-1,2-dihydro-3H-benzo[e]indole-3-carboxylate) 在 palladium on activated charcoal 甲酸铵 作用下， 以 四氢呋喃 为溶剂， 以85%的产率得到Tert-butyl 1-(chloromethyl)-7-[[8-[[1-(chloromethyl)-5-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonyl]-1,2-dihydrobenzo[e]indol-7-yl]amino]-8-oxooctanoyl]amino]-5-hydroxy-1,2-dihydrobenzo[e]indole-3-carboxylate
  参考文献：
  名称：

  Design, synthesis and cytotoxicity evaluation of 1-chloromethyl-5-hydroxy-1,2-dihydro-3 H -benz[ e ]indole ( seco -CBI) dimers

  摘要：

  Three types of 1-chloromethyl-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI) dimers were designed, synthesized and evaluated in vitro by NCI against nine types of cancer cells. Biological results showed that the antitumor activities of these seco-CBI dimers were strongly related to the position and length of the linker and generally with potency increasing in the order of C7-C7 dimers (22i-iv) < C7-N3 dimers (28i-iv) < N3-N3 dimers (25i-iv). Compound 28iv showed significant activity against CCRT-CEM, HL-60 (TB), MOLT-4, and SR leukemia cell lines and the MCF 7 breast cancer cell line with GI(50) values < 0.01 mu M. N3-N3 dimer 25i displayed striking potency against leukemia, CNS cancer, melanoma and prostate cancer cell lines with GI(50) values < 0.01 mu M against all the cell lines and showed the highest overall potency of the agents examined (GMG = 0.0120 mu M). (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(00)00088-2
• 作为产物：
  描述：

  N-(tert-butyloxycarbonyl)-N-(3-chloro-2-propen-1-yl)-6-(9-fluorenylmethyloxy-carbonylamino)-4-benzyloxy-1-iodo-2-naphthylamine 在 偶氮二异丁腈 、 四丁基氟化铵 、 三正丁基氢锡 、 三乙胺 作用下， 以 四氢呋喃 、 苯 为溶剂， 反应 7.0h， 生成 di-tert-butyl 7,7'-(octanedioylbis(azanediyl))bis(5-(benzyloxy)-1-(chloromethyl)-1,2-dihydro-3H-benzo[e]indole-3-carboxylate)
  参考文献：
  名称：

  Design, synthesis and cytotoxicity evaluation of 1-chloromethyl-5-hydroxy-1,2-dihydro-3 H -benz[ e ]indole ( seco -CBI) dimers

  摘要：

  Three types of 1-chloromethyl-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI) dimers were designed, synthesized and evaluated in vitro by NCI against nine types of cancer cells. Biological results showed that the antitumor activities of these seco-CBI dimers were strongly related to the position and length of the linker and generally with potency increasing in the order of C7-C7 dimers (22i-iv) < C7-N3 dimers (28i-iv) < N3-N3 dimers (25i-iv). Compound 28iv showed significant activity against CCRT-CEM, HL-60 (TB), MOLT-4, and SR leukemia cell lines and the MCF 7 breast cancer cell line with GI(50) values < 0.01 mu M. N3-N3 dimer 25i displayed striking potency against leukemia, CNS cancer, melanoma and prostate cancer cell lines with GI(50) values < 0.01 mu M against all the cell lines and showed the highest overall potency of the agents examined (GMG = 0.0120 mu M). (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(00)00088-2